I nɔ kin izi fɔ tɔk bɔt aw i kin tan lɛk we dɛn no se yu gɛt prɔstat kansa. Dɔn bak, dɛn nɔ kin ebul fɔ kɔntrol di kansa wit standad tritmɛnt dɛn, ɛn i kin rili bad fɔ no se i dɔn skata to ɔda pat dɛn na di bɔdi. Bɔt bikɔs mɛrɛsin sayɛns dɔn go bifo, nyu ɛn fayn tritmɛnt dɛn dɔn kam naw fɔ dɛn kayn kes dɛn ya we nɔ izi. Wan pan di nyu tritmɛnt dɛm wae de briŋ dis kayn op na PSMA targeted therapy. Lɛ wi tɔk bɔt dis rili simpul wan tide.
Wetin na PSMA-Targeted Therapy?
Fɔ tɔk am simpul wan, dis na tritmɛnt we rili advans we de tɔch ɛn pwɛl di kansa sɛl dɛn nɔmɔ. di PSMA we de insay dis nem tinap fɔ Prostate-Specific Membrane Antigen . Pan ɔl we dis kin tan lɛk se i kɔmplikt smɔl pan wɔd dɛn, di we aw i de wok rili simpul.
Tink bɔt prɔstat kansa sɛl dɛn lɛk wan ami we gɛt ɛnimi dɛn. Ɛni wan pan dɛn ɛnimi sojaman ya gɛt spɛshal insignia, we na ‘badge’, na dɛn yunifom. Dat badge na PSMA. dis protin we dεn kכl PSMA, de insay bכku bכku wan na di sεl dεm we de fכm di prכstat kεnsar.
So wetin yu de du na dis tritmɛnt na fɔ injekt wan drɔg insay di bɔdi we de wok lɛk ‘smat mishɔl’. dis dכg de travul כlsay na di bכdi, i de fכn כnli kεnsar sεl dεm we gεt da spεshal ‘badge’ we dεn kכl PSMA, εn i de atak dεm. afta dat, wan redioaktiv sכbstans (`Lutetium-177`) we de insay di dכg de pwεl כnli da kεnsar sεl de. Dɛn kin kɔl dis bak `Lu177-PSMA` tɛrapi. Sɔntɛnde yu go yɛri bak di brand nem `PluvictoTM`.
di big advantej fכ dis na dat i nכ lεk fכ jכs shot כlman, bכt fכ no di εksakεt εnεmi εn tכk to dεm, so di damej to hεlty, gud sεl dεm na wi bכdi nכ de bכku.
Wetin na di prɔstat gland?
We wi de pan am, lɛ wi tɔk smɔl bɔt di prɔstat gland. Dis na tin we dɛn kin si pan man dɛn nɔmɔ. dis gland de dכn di blad, bifo di an. Bɔku tɛm, i kin tan lɛk big walnut.
Uskayn kes dɛm dɛn kin yuz dis tritmɛnt?
Dis nɔto tritmɛnt fɔ ɔl di wan dɛn we gɛt prɔstat kansa. Dɛn kin advays am fɔ di wan dɛn we dɔn go bifo, we min se di kansa dɔn skata fa fawe pas di prɔstat gland (mɛtastatik prɔstat kansa) . Dis min se di kansa dɔn skata to ɔda pat dɛn na di bɔdi lɛk di bon dɛn ɔ di limf no dɛm.
Dɔn bak, dɔktɔ dɛn kin tink bɔt dis tritmɛnt we dɛn nɔ kin ebul fɔ kɔntrol di kansa igen bay kɔmɔn tritmɛnt dɛn lɛk ɔpreshɔn, raytin, ɛn ɔmon tɛrapi.
Dis tritmɛnt go ebul fɔ mɛn kansa kpatakpata?
Dis na kwɛstyɔn we rili impɔtant. Fɔ tɔk tru, nɔto so. PSMA-targeted therapy nɔto mɛrɛsin fɔ kansa.
So wetin kin apin wit dis? Di men gol dɛm fɔ dis tritmɛnt na:
- Fɔ shrink ɔ mek di tumbu dɛn smɔl.
- Slow di rεt fכ mכr kεnsar growth.
- Fɔ ridyus di sayn dɛm lɛk pen we kansa kin kam wit.
- Fɔ mek di pɔsin in layf lɔng ɛn fɔ mek in layf bɛtɛ.
Fɔ tɔk am simpul wan, i kin ɛp fɔ fɛt kansa ɛn kɔntrol am. Afta dis tritmɛnt, yu kin gɛt sɔm tɛm fɔ ``rɛmishɔn`` we yu nɔ gɛt ɛni sayn fɔ kansa ɛn di sik nɔ de wok. Bɔt i impɔtant fɔ kɔntinyu fɔ fala yu dɔktɔ.
Wetin kin apin bifo dɛn bigin fɔ trit am?
Bɔku tɛm, bifo yu du dis tritmɛnt, yu go dɔn gɛt ɔda tritmɛnt dɛn lɛk kemotɛrapi ɔ ɔmon tɛrapi. Yu dɔktɔ go jɔs tɔk bɔt dis opshɔn wit yu if dɛn tin ya nɔ dɔn gɛt di rizɔlt we yu want.
Bifo yu bigin fɔ trit yu, yu dɔktɔ go chɛk yu gud gud wan. Yu fɔ tɔk to am bɔt yu kɔmplit mɛdikal istri, di tritmɛnt dɛn we yu bin dɔn gɛt trade, ɛn di mɛrɛsin dɛn we yu de tek naw. Dis na fayn tɛm fɔ aks ɛni kwɛstyɔn we yu gɛt.
Apat frɔm dat, dɛn kin ɔda fɔ mek dɛn du bɔku blɔd tɛst ɛn spɛshal skan dɛn. Dɛn kin yuz dɛn skan ya fɔ no ustɛm di kansa sɛl dɛn de na di bɔdi.
| Skan | Fɔ tɔk am simpul wan, wetin kin apin wit dis? |
|---|---|
| CT Skan (Kɔmpyut Tomografi) . | dis de mek wan tri dimenshכnal (3D) imej fכ di bon dεm εn di sכft tisu dεm we de insay di bכdi. Dis kin ɛp fɔ si usay di kansa tɔŋ dɛn de ɛn dɛn saiz. |
| MRI skan (Magnetik Rizɔnans Imej) . | We dɛn yuz big magnet ɛn redio wev dɛn, dɛn kin gɛt rili klia, ditayli pikchɔ dɛn bɔt di bɔdi in sɔft tisu dɛn. |
| PSMA PET skan we dɛn kin du | Dis na di skan we impɔtant pas ɔl fɔ dis tritmɛnt. insay dis, lεk di tritmεnt we dεn bin du bifo, dεn injεkt wan redioaktiv sכbstans we de dεtekt PSMA insay di bכdi. Bɔt di rizin fɔ dis nɔto fɔ pwɛl di kansa sɛl dɛn, bɔt fɔ mak usay dɛn de na di skan. Dis kin rili fayn fɔ fɛn ivin di smɔl smɔl kansa sɛl. |
We dɔktɔ dɛn jɔyn ɔl dɛn skan ya, dɛn kin mek wan kɔmplit map fɔ sho aw di kansa dɔn skata ɔlsay na yu bɔdi.
Wetin kin apin we dɛn de trit am?
Fɔ gi dis tritmɛnt nɔr kin at lɛk aw yu kin tink.
- Bɔku tɛm, dɛn kin put smɔl kanula insay wan vein na yu an, ɛn dɛn kin gi di mɛrɛsin insay yu bɔdi tru am, lɛk salin sɔlvushɔn.
- dis injεkshכn gεt di redioaktiv sכbstans ``Lutetium-177'' we wi bin tכk bכt.
- Di vaksin prɔses kin tek sɔm minit nɔmɔ.
- Dɛn kin gi yu mɛrɛsin bifo tɛm fɔ kɔntrol tin dɛn lɛk nɔs ɛn vɔmit.
- Dis na ɔutpatient prosidur . Dis min se yu nɔ nid fɔ de na ɔspitul. Dɛn go de wach yu fɔ sɔm awa afta di tritmɛnt ɛn afta dat yu kin go na os we yu kɔndishɔn stebul.
Aw lɔng dis tritmɛnt kin tek?
Dɛn kin schedul dis tritmɛnt ɛvri siks wik . Siks dis kayn tritmɛnt saykl dɛn fɔ dɔn. Dis min se di tכtal tritmεnt tεm na lεk 8 mכnt (36 wik).
Afta wan tritmɛnt saykl ɛn bifo di nɛks wan, yu dɔktɔ go du blɔd tɛst fɔ si aw yu bɔdi de du di tritmɛnt ɛn fɔ wach fɔ di sayd ɛfɛkt dɛm.
Wetin na di bɛnifit dɛn we dis tritmɛnt de gi?
Di men bɛnifit fɔ dis tritmɛnt na dat i kin kɔntrol di prɔstat kansa we dɔn go bifo we nɔ de du ɔda tritmɛnt, i kin mek di sik nɔ bɔku, ɛn i kin mek di sik nɔ bɔku.
di כda big advantej fכ dis na dat i de spεshal tכk εn pwεl di PSMA protin we de insay di kεnsar sεl dεm, so na bכku bכku damej de pan hεlty sεl dεm na di bכdi. Dis tan lɛk atak we dɛn rili want fɔ atak.
Ɛni bad bad tin dɛn de we kin apin to am? Wetin na di prɔblɛm dɛn we kin apin?
Jɔs lɛk ɛni ɔda tritmɛnt fɔ kansa, sɔm sayd ɛfɛkt dɛn de we kin apin. Bɔt nɔto ɔlman kin ɛkspiriɛns dɛn di sem we. Sɔm pipul dɛn nɔ kin gɛt dɛn kayn tin ya.
| Kɔmɔn sayd ɛfɛkt dɛn | Smɔl ɛksplen bɔt dat |
|---|---|
| Dray mɔt | Dis mɛrɛsin kin gɛt sɔm ifɛkt bak pan di saliva gland dɛm, so yu kin fil lɛk se yu mɔt ful-ɔp wit saliva. |
| Dray yay | Di wata we de kɔmɔt na di yay kin afɛkt, we kin mek di yay fil dray ɛn grit. |
| Taya | Fɔ fil se yu taya pasmak. Dis kin kɔmɔn fɔ bɔku tritmɛnt dɛn we gɛt kansa. |
| Nɔs ɛn vɔmit | Di dɔktɔ go gi yu mɛrɛsin fɔ kɔntrol dis sik. |
| Fil fɔ it | Di want fɔ it ɛn di apɛtit kin stɔp. |
| Di blɔd sɛl dɛn we de go dɔŋ | Di lɛvɛl we di ɛmoglobin ɛn di pletlɛt dɛn de na di blɔd kin smɔl smɔl. Dis na di rizin we mek dɛn kin du blɔd tɛst ɔltɛm. |
Nɔ wɔri bɔt dɛn sayd ɛfɛkt ya. Bɔku pan dɛn kin ebul fɔ kɔntrol. E fayn fɔ tɔk to yu dɔktɔ bɔt ɛni diskɔmfɔt we yu fil.
Tin dɛn we yu kin du fɔ mek yu tritmɛnt izi
Fɔ liv wit kansa ɛn fɔ gɛt tritmɛnt nɔr izi. Dɛn tin ya go ɛp fɔ mek dis tɛm izi fɔ yu smɔl.
Una fɔ rɛst fayn fayn wan.
We yu kam fɔ no se yu gɛt kansa, di strɛs we yu kin gɛt we yu de tink bɔt tritmɛnt kin mek i nɔ izi fɔ slip. Bɔt yu bɔdi rili nid fɔ rɛst. Nɔto jɔs wae yu nɔr de slip fayn, dat kin afɛkt yu maynd, bɔt e kin mek i nɔr izi fɔ bia wit de strɛs wae de kam wit tritmɛnt.
- Nɔ it ebi ebi it, kɔfi, ɛn rɔm bifo yu go slip.
- Tin dɛm lɛk fɔ tink gud wan ɛn fɔ rayt jɔnal kin ɛp yu fɔ fri yu tink ɛn rilaks yu maynd.
- Rɛst we yu bɔdi tɛl yu fɔ rɛst, nɔto we yu ebul.
Shek yu bɔdi smɔl we yu ebul.
If yu de fil taya, i go fayn fɔ mek yu du sɔm layt ɛksesaiz. Ivin sɔntin lɛk fɔ waka kin ɛp fɔ mek yu at ɛn yu lɔng dɛn wok fayn, mek yu mɔsul dɛn strɔng, ɛp yu imyun sistɛm, ɛn mek yu nɔ taya ɛn strɛs.
Bɔt mɛmba se bifo yu bigin ɛni ɛksesaiz, i rili impɔtant fɔ go to yu dɔktɔ.
It di it we balans.
Nɔs ɛn nɔ want fɔ it kin mek yu nɔ want fɔ it, bɔt i rili impɔtant fɔ gi di bɔdi di tin dɛn we yu nid insay dis tɛm.
- Protin dɛn we nɔ gɛt bɔku fat (fish, chukchuk) .
- Vɛjitebul ɛn frut dɛn
- Ɔl di grens dɛn
- Di it dɛn we dɛn kin mek wit milk we nɔ gɛt bɔku fat
Ad tin dɛn lɛk dɛn tin ya to yu it. Tɔk to yu dɔktɔ bɔt dis. I kin rifer yu to wan dɔktɔ we gɛt ɔnkɔlɔji sɛtifiket fɔ it.
Gɛt di sɔpɔt we yu nid.
Nɔto yu wan de na dis waka. We yu tɔk to yu fambul ɔ yu tayt padi bɔt di tin dɛn we yu de fred, di sɔri-at, ɛn wɔri we yu de wɔri, dat kin rili kɔrej yu. Yu kin aks yu dɔktɔ bak bɔt sɔpɔt grup dɛm usay ɔda pipul dɛm wae dɔn gɛt dis kayn ɛkspiriɛns kin go, ɔr bɔt pɔrsin wae de gi advays bɔt mɛntɛl hεlth.
Dis tritmɛnt de na Sri Lanka?
PSMA-targeted therapy na tritmɛnt we dɛn dɔn gri fɔ ɛn gri wit bay intanashɔnal institiushɔn dɛn lɛk FDA na Amɛrika. Insay Sri Lanka, big big ɔspitul dɛn we de mɛn kansa gɛt di pawa bak fɔ gɛt dɛn kayn advans tritmɛnt dɛn ya.
Bɔt di bɛst ɛn di wangren we fɔ gɛt di kɔrɛkt ɛn klia infɔmeshɔn bɔt if dis rayt fɔ yu, usay yu go gɛt dis tritmɛnt na Sri Lanka, ɛn aw bɔku i de kɔst na fɔ tɔk dairekt to yu ɔnkɔlɔjis. I go stɔdi yu sik gud gud wan ɛn gayd yu fɔ di tritmɛnt we fit yu pas ɔl.
Mɛsej we dɛn kin kɛr go na os
- PSMA-targeted therapy na advans tritmɛnt fɔ prɔstat kansa we dɔn skata ɔlsay na di bɔdi ɛn ɔda tritmɛnt dɛn nɔ de kɔntrol am.
- Pan ɔl we dis nɔto tritmɛnt we de mɛn kansa kpatakpata, i kin rili ɛp fɔ kɔntrol di sik, fɔ ridyus di sayn dɛm, ɛn fɔ mek pipul dɛn liv bɛtɛ layf.
- Wan pan di big bɛnifit dɛn we dis kin gɛt na dat i kin tɔch di kansa sɛl dɛn nɔmɔ, ɛn dis kin mek di sɛl dɛn we gɛt wɛlbɔdi nɔ pwɛl.
- Sɔm bad tin dɛn lɛk we yu mɔt dray ɛn we yu taya kin apin, bɔt we dɛn de fɔ kɔntrol dɛn.
- I impɔtant fɔ tɔk to yu dɔktɔ opin wan bɔt dis tritmɛnt ɔr ɛni prɔblɛm we yu go gɛt. Mɛmba ɔltɛm se nɔto yu wangren de du dis waka.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt